Education
About Us
Working with TipRanks
Follow Us
PureTech Health (GB:PRTC)
:PRTC
PRTC Stock Chart & Stats
134.80p
0.20p(0.14%)
At close: 4:00 PM EST
134.80p
0.20p(0.14%)
Day’s Range― - ―
52-Week Range100.40p - 178.00p
Previous CloseN/A
Volume88.39K
Average Volume (3M)474.53K
Market Cap
£299.20M
Enterprise Value74.66M
Total Cash (Recent Filing)£321.55M
Total Debt (Recent Filing)£20.92M
Price to Earnings (P/E)8.8
Beta2.05
Next Earnings
Apr 23, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding241,684,040
10 Day Avg. Volume282,898
30 Day Avg. Volume474,529
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.22
Price to Sales (P/S)117.44
P/FCF Ratio-3.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-36.99
Revenue Forecast (FY)£278.21M
PureTech Health News
PRTC FAQ
What was PureTech Health’s price range in the past 12 months?
PureTech Health lowest share price was 100.40p and its highest was 178.00p in the past 12 months.
What is PureTech Health’s market cap?
PureTech Health’s market cap is £299.20M.
When is PureTech Health’s upcoming earnings report date?
PureTech Health’s upcoming earnings report date is Apr 23, 2026 which is in 132 days.
How were PureTech Health’s earnings last quarter?
PureTech Health released its earnings results on Aug 28, 2025. The company reported -0.141p earnings per share for the quarter, beating the consensus estimate of -0.151p by 0.01p.
Is PureTech Health overvalued?
According to Wall Street analysts PureTech Health’s price is currently Overvalued.
Does PureTech Health pay dividends?
PureTech Health does not currently pay dividends.
What is PureTech Health’s EPS estimate?
PureTech Health’s EPS estimate is -0.14.
How many shares outstanding does PureTech Health have?
PureTech Health has 241,684,040 shares outstanding.
What happened to PureTech Health’s price movement after its last earnings report?
PureTech Health reported an EPS of -0.141p in its last earnings report, beating expectations of -0.151p. Following the earnings report the stock price went down -5.522%.
Which hedge fund is a major shareholder of PureTech Health?
Currently, no hedge funds are holding shares in GB:PRTC
PureTech Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth £291.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.31%
12-Months-Change
Fundamentals
Return on Equity
15.04%
Trailing 12-Months
Asset Growth
-12.00%
Trailing 12-Months
Company Description
PureTech Health
PureTech Health (PRTC) is a biotechnology company focused on discovering, developing, and commercializing innovative therapies for serious diseases. The company operates primarily in the health and biotechnology sectors, leveraging its expertise in drug development to create a diverse pipeline of therapeutic candidates across various domains, including immunology, neurology, and oncology. PureTech also engages in collaborations and partnerships with other biotech and pharmaceutical companies to advance its proprietary technologies and products.
Technical Analysis
Bioventix
―
Scancell Holdings
―
Oxford BioMedica
―
4basebio UK Societas
―
Oxford Nanopore Technologies PLC
―
Options Prices
Currently, No data available
---